Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Equity (Deficit) - USD ($) $ in Thousands	Total	Series A Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Series A Convertible Preferred Stock	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		0
Beginning balance at Dec. 31, 2021		$ 0
Ending balance (in shares) at Mar. 31, 2022		0
Ending balance at Mar. 31, 2022		$ 0
Beginning balance (in shares) at Dec. 31, 2021			112,996,568
Beginning balance at Dec. 31, 2021	$ 55,191		$ 11	$ 198,602		$ (143,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in Shares)			88,808
Issuance of common stock upon exercise of stock options	48			48
Issuance of common stock for restricted stock units vesting (in shares)			321,098
Issuance of common stock for employee stock purchase plan	3,336			3,336
Net loss	(28,758)					(28,758)
Ending balance (in shares) at Mar. 31, 2022			113,406,474
Ending balance at Mar. 31, 2022	29,817		$ 11	201,986		(172,180)
Beginning balance (in shares) at Dec. 31, 2022		0
Beginning balance at Dec. 31, 2022		$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Temporary equity, shares issued (in shares)		30,000
Issuance of Series A convertible preferred stock		$ 3,867
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs	(311)			(311)
Accretion on Series A convertible preferred stock	(653)	$ 653			$ (653)
Ending balance (in shares) at Mar. 31, 2023		30,000
Ending balance at Mar. 31, 2023		$ 4,520
Beginning balance (in shares) at Dec. 31, 2022			115,388,135
Beginning balance at Dec. 31, 2022	(10,635)		$ 12	212,111		(222,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of SVB Warrants (Note 4)	43			43
Issuance of common stock upon exercise of stock options (in Shares)			252,757
Issuance of common stock upon exercise of stock options	55			55
Issuance of common stock for employee stock purchase plans			211,468
Issuance of common stock for restricted stock units vesting (in shares)			1,613,578
Issuance of common stock for employee stock purchase plan	101			101
Share-based compensation	2,789			2,789
Net loss	(11,867)					(11,867)
Ending balance (in shares) at Mar. 31, 2023			117,465,938
Ending balance at Mar. 31, 2023	$ (20,478)		$ 12	$ 214,135		$ (234,625)